Vascular Microthrombosis Associated with Increased Interleukin-6. A Severe Acute Respiratory Distress Syndrome in COVID-19 Patients Treated with Tocilizumab
Excerpt
Thrombosis is an important pathology in the deterioration of COVID-19 patient [...]
Share and Cite
Mohebbi, N.; Abedini, A.; Lashgari, R.; Razavi, F.; Varahram, M.; Kiani, A. Vascular Microthrombosis Associated with Increased Interleukin-6. A Severe Acute Respiratory Distress Syndrome in COVID-19 Patients Treated with Tocilizumab. Adv. Respir. Med. 2020, 88, 468-469. https://doi.org/10.5603/ARM.a2020.0123
Mohebbi N, Abedini A, Lashgari R, Razavi F, Varahram M, Kiani A. Vascular Microthrombosis Associated with Increased Interleukin-6. A Severe Acute Respiratory Distress Syndrome in COVID-19 Patients Treated with Tocilizumab. Advances in Respiratory Medicine. 2020; 88(5):468-469. https://doi.org/10.5603/ARM.a2020.0123
Chicago/Turabian StyleMohebbi, Niayesh, Atefeh Abedini, Reza Lashgari, Fatemeh Razavi, Mohammad Varahram, and Arda Kiani. 2020. "Vascular Microthrombosis Associated with Increased Interleukin-6. A Severe Acute Respiratory Distress Syndrome in COVID-19 Patients Treated with Tocilizumab" Advances in Respiratory Medicine 88, no. 5: 468-469. https://doi.org/10.5603/ARM.a2020.0123